Recro Pharma Statistics Share Statistics Recro Pharma has 84.89M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 84.89M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 69.97M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 629.29K, so 0% of the outstanding
shares have been sold short.
Short Interest 629.29K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 4.05
Valuation Ratios The PE ratio is -14.99 and the forward
PE ratio is null.
Recro Pharma's PEG ratio is
0.25.
PE Ratio -14.99 Forward PE n/a PS Ratio 2.1 Forward PS n/a PB Ratio 3.39 P/FCF Ratio -21.54 PEG Ratio 0.25
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Recro Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.07,
with a Debt / Equity ratio of 0.72.
Current Ratio 1.07 Quick Ratio 0.86 Debt / Equity 0.72 Debt / EBITDA -11.76 Debt / FCF -4.55 Interest Coverage 0.36
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $511.54K Profits Per Employee $-71.75K Employee Count 185 Asset Turnover 0.62 Inventory Turnover 7.45
Taxes Income Tax 132K Effective Tax Rate -1%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.12, so Recro Pharma's
price volatility has been higher than the market average.
Beta 1.12 52-Week Price Change n/a 50-Day Moving Average 1.71 200-Day Moving Average n/a Relative Strength Index (RSI) 67.93 Average Volume (20 Days) 128,488
Income Statement In the last 12 months, Recro Pharma had revenue of 94.64M
and earned -13.27M
in profits. Earnings per share was -0.14.
Revenue 94.64M Gross Profit 18.14M Operating Income -3.57M Net Income -13.27M EBITDA -3.57M EBIT -23.11M Earnings Per Share (EPS) -0.14
Full Income Statement Balance Sheet The company has 8.1M in cash and 42.01M in
debt, giving a net cash position of -33.92M.
Cash & Cash Equivalents 8.1M Total Debt 42.01M Net Cash -33.92M Retained Earnings -278.91M Total Assets 153.47M Working Capital 3.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1M
and capital expenditures -8.24M, giving a free cash flow of -9.24M.
Operating Cash Flow -1M Capital Expenditures -8.24M Free Cash Flow -9.24M FCF Per Share -0.1
Full Cash Flow Statement Margins Gross margin is 19.17%, with operating and profit margins of -3.78% and -14.03%.
Gross Margin 19.17% Operating Margin -3.78% Pretax Margin -13.89% Profit Margin -14.03% EBITDA Margin -3.78% EBIT Margin -3.78% FCF Margin -9.77%
Dividends & Yields REPH does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for REPH.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 22, 2019. It was a
forward
split with a ratio of 223:200.
Last Split Date Nov 22, 2019 Split Type forward Split Ratio 223:200
Scores Altman Z-Score -1.25 Piotroski F-Score 2
